Systematic pulmonary embolism follow-up: why we should all do it!
- PMID: 38485183
- DOI: 10.1183/13993003.00253-2024
Systematic pulmonary embolism follow-up: why we should all do it!
Conflict of interest statement
Conflict of interest: L.S. Howard has received honoraria for speaking from Janssen, MSD, Ferrer and Aerovate, research funding from MSD and Janssen, honoraria for advisory and steering committees from Janssen, MSD, Gossamer Bio, Altavant and Apollo, travel and conference support from Janssen, and has stock in iIOWNA, Circular, Calibre Biometrics and ATXA Therapeutics. L.C. Price reports research funding, travel and conference support from Janssen and Ferrer, and honoraria for advisory and steering committees from Janssen and Roivant Pharmaceuticals.
Comment on
-
Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry.Eur Respir J. 2024 Mar 14;63(3):2300846. doi: 10.1183/13993003.00846-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38302154 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical